These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 23150107)

  • 21. Bleeding peptic ulcer in the elderly: risk factors and prevention strategies.
    Zullo A; Hassan C; Campo SM; Morini S
    Drugs Aging; 2007; 24(10):815-28. PubMed ID: 17896831
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Role of Helicobacter pylori in drug-induced gastrointestinal bleeding].
    Chaussade S; Abitbol V
    Presse Med; 2003 Nov; 32(37 Pt 2):S60-3. PubMed ID: 14763358
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Should we eradicate Helicobacter pylori infection in patients receiving nonsteroidal anti-inflammatory drugs or low-dose aspirin?
    Chan FK
    Chin J Dig Dis; 2005; 6(1):1-5. PubMed ID: 15667550
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Eradication of Helicobacter pylori does not reduce the incidence of gastroduodenal ulcers in patients on long-term NSAID treatment: double-blind, randomized, placebo-controlled trial.
    de Leest HT; Steen KS; Lems WF; Bijlsma JW; van de Laar MA; Huisman AM; Vonkeman HE; Houben HH; Kadir SW; Kostense PJ; van Tulder MW; Kuipers EJ; Boers M; Dijkmans BA
    Helicobacter; 2007 Oct; 12(5):477-85. PubMed ID: 17760715
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Risk of gastrointestinal bleeding with aspirin and platelet antiaggregants].
    Nardulli G; Lanas A
    Gastroenterol Hepatol; 2009 Jan; 32(1):36-43. PubMed ID: 19174098
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Eradication of Helicobacter pylori and risk of peptic ulcers in patients starting long-term treatment with non-steroidal anti-inflammatory drugs: a randomised trial.
    Chan FK; To KF; Wu JC; Yung MY; Leung WK; Kwok T; Hui Y; Chan HL; Chan CS; Hui E; Woo J; Sung JJ
    Lancet; 2002 Jan; 359(9300):9-13. PubMed ID: 11809180
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Challenges in managing NSAID-associated gastrointestinal tract injury.
    Goldstein JL
    Digestion; 2004; 69 Suppl 1():25-33. PubMed ID: 15001832
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New look at antiplatelet agent-related peptic ulcer: an update of prevention and treatment.
    Hsu PI
    J Gastroenterol Hepatol; 2012 Apr; 27(4):654-61. PubMed ID: 22283743
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Peptic ulcer: facts and questions -- 2010].
    Hagymási K; Tulassay Z
    Orv Hetil; 2010 Jun; 151(26):1054-61. PubMed ID: 20558352
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk factors for peptic ulcer bleeding in terms of Helicobacter pylori, NSAIDs, and antiplatelet agents.
    Kang JM; Kim N; Lee BH; Park HK; Jo HJ; Shin CM; Lee SH; Park YS; Hwang JH; Kim JW; Jeong SH; Lee DH; Jung HC; Song IS
    Scand J Gastroenterol; 2011 Nov; 46(11):1295-301. PubMed ID: 21815866
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Bleeding peptic ulcer. Prevalence of Helicobacter pylori and use of nonsteroidal anti-inflammatory drugs/acetylsalicylic acid].
    Vestergård A; Bredahl K; de Muckadell OB; Pedersen OB; Hansen JM
    Ugeskr Laeger; 2009 Jan; 171(4):235-9. PubMed ID: 19174039
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NSAID-induced gastrointestinal damage: current clinical management and recommendations for prevention.
    Lanas A; Ferrandez A
    Chin J Dig Dis; 2006; 7(3):127-33. PubMed ID: 16808792
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Advances in the pharmacotherapeutic management of refractory peptic ulcers.
    Borao Laguna C; Lanas A
    Expert Opin Pharmacother; 2023 May; 24(7):825-833. PubMed ID: 37027144
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [HP eradication prevents recurrent hemorrhages caused by acetylsalicylic acid].
    Labenz J
    MMW Fortschr Med; 2013 Jun; 155(12):31. PubMed ID: 23923307
    [No Abstract]   [Full Text] [Related]  

  • 35. Non-steroidal anti-inflammatory drug toxicity in the upper gastrointestinal tract.
    Sung J; Russell RI; Nyeomans ; Chan FK; Chen S; Fock K; Goh KL; Kullavanijaya P; Kimura K; Lau C; Louw J; Sollano J; Triadiafalopulos G; Xiao S; Brooks P
    J Gastroenterol Hepatol; 2000 Oct; 15 Suppl():G58-68. PubMed ID: 11100995
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term follow-up of patients with gastric outlet obstruction related to peptic ulcer disease treated with endoscopic balloon dilatation and drug therapy.
    Cherian PT; Cherian S; Singh P
    Gastrointest Endosc; 2007 Sep; 66(3):491-7. PubMed ID: 17640640
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Primary prevention of ulcers in patients taking aspirin or NSAIDs.
    Med Lett Drugs Ther; 2010 Mar; 52(1333):17-9. PubMed ID: 20300052
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of Helicobacter pylori eradication in aspirin or non-steroidal anti-inflammatory drug users.
    Papatheodoridis GV; Archimandritis AJ
    World J Gastroenterol; 2005 Jul; 11(25):3811-6. PubMed ID: 15991274
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Strategies to reduce the GI risks of antiplatelet therapy.
    Scheiman JM
    Rev Cardiovasc Med; 2005; 6 Suppl 4():S23-31. PubMed ID: 17710073
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of NSAIDs and infection with Helicobacter pylori--what does the rheumatologist need to know?
    Kiltz U; Zochling J; Schmidt WE; Braun J
    Rheumatology (Oxford); 2008 Sep; 47(9):1342-7. PubMed ID: 18477642
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.